Amvuttra (vutrisiran) is a prescription drug that’s used to treat nerve damage related to a rare genetic condition. Amvuttra is given as an injection under your skin by a healthcare professional ...

He noted robust demand for AMVUTTRA and ONPATTRO in the U.S., with a 42% annual growth in TTR sales. CFO Jeff Poulton stated, "For the first time, we achieved full-year non-GAAP operating profit ...

With sales of Onpattro and Amvuttra increasing by 33% year over year and 30% in the fourth quarter of 2024, there is already lots of momentum without the new indication. While entrance into the ...

Like other drugs, Amvuttra (vutrisiran) can cause side effects, such as difficulty breathing and low vitamin A levels. If you can’t tolerate side effects of Amvuttra, talk with your doctor.

Alnylam's lead candidate for ATTR-CM, Amvuttra (vutrisiran), has shown promising results in the HELIOS-B clinical trial. The top-line data demonstrated a significant reduction in mortality ...

Alnylam Pharmaceuticals ALNY reported fourth-quarter 2024 adjusted earnings of 6 cents per share, in contrast with the Zacks Consensus Estimate of a loss of 21 cents. The company had incurred a ...

Alnylam's lead candidate for ATTR-CM, Amvuttra (vutrisiran), has shown promising results in the HELIOS-B clinical trial. The top-line data demonstrated a significant reduction in mortality, with ...

Marni Rose McFall is a Newsweek reporter based in London, U.K. Her focus is on U.S. politics, social affairs and popular culture. She has covered fashion, culture, art and music extensively.

Showing strong emotions, they have slapped a fresh batch of bumper stickers on their EVs, pledging their undying love for Tesla’s electric vehicles — while disapproving Elon Musk’s latest ...

TKMAXX has launched an enormous double sticker sale with huge discounts on big brands. Double yellow sticker season is upon us and one reseller is taking full advantage of the sales. George Ross ...